Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Sorting and Selecting Cancer Cells by Their Motility Will Advance Understanding of Metastatic Processes

By LabMedica International staff writers
Posted on 03 Jun 2015
In order to develop a better understanding of the mechanisms that cause some cancer cells to break away from the primary tumor and migrate to other parts of the body, a team of cancer researchers has created an instrument for sorting and selecting cancer cells based on their motility.

Tumor cell migration toward and into capillaries is an early and key event in cancer metastasis, yet not all cancer cells are imbued with the same capability to do so. More...
This heterogeneity within a tumor is a fundamental property of cancer.

Conventional in vitro migration platforms have so far related to cell populations as an aggregate, which has led to a masking of intrinsic differences among cells. While some migration assays have reported the ability to resolve single cells, these platforms did not provide for selective retrieval of the distinct migrating and non-migrating cell populations for further analysis.

Therefore, to study the intrinsic differences in cells responsible for chemotactic heterogeneity, investigators at the University of Michigan (Ann Arbor, USA) developed a single-cell migration platform so that individual cells’ migration behavior could be studied and the heterogeneous population sorted based upon chemotactic phenotype. Furthermore, after migration, highly chemotactic and non-chemotactic cells were retrieved and proved viable for later molecular analysis of their differences.

In addition, as described in a paper published in the May 18, 2015, online edition of the journal Scientific Reports, the investigators modified the migration channel to resemble lymphatic capillaries to better understand how certain cancer cells are able to move through geometrically confining spaces.

"This work demonstrates an elegant approach to the study of cancer cell metastasis by combining expertise in engineering and biology," said senior author Dr. Euisik Yoon, professor of electrical engineering, computer science, and biomedical engineering at the University of Michigan. "In past decades, engineers have developed biological tools with better resolution, higher sensitivity, selectivity, and higher throughput. However, without compelling applications, these engineering tools have little practical relevance. The goal of our lab is to develop tools that can be widely disseminated to the biology community to eventually impact clinical care for patients."

Related Links:

University of Michigan



New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Collection and Transport System
PurSafe Plus®
New
Gel Cards
DG Gel Cards
New
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Over 100 new epigenetic biomarkers may help predict cardiovascular disease risk (Photo courtesy of 123RF)

Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk

Cardiovascular disease is a leading cause of death worldwide, yet predicting individual risk remains a persistent challenge. Traditional risk factors, while useful, do not fully capture biological changes... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.